PROCEPT BioRobotics Corporation Increase Decrease In Operating Lease Liability
PROCEPT BioRobotics Corporation (PRCT) reported Increase Decrease In Operating Lease Liability of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-02-26
- PROCEPT BioRobotics Corporation increase decrease in operating lease liability for the quarter ending 2025-12-31 was $0.00.
- PROCEPT BioRobotics Corporation increase decrease in operating lease liability for the quarter ending 2025-09-30 was $0.00.
- PROCEPT BioRobotics Corporation increase decrease in operating lease liability for the quarter ending 2025-06-30 was $0.00.
- PROCEPT BioRobotics Corporation increase decrease in operating lease liability for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- PROCEPT BioRobotics Corporation increase decrease in operating lease liability for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation increase decrease in operating lease liability for fiscal 2024 was $2.60M, a 47.97% decline from fiscal 2023.
- PROCEPT BioRobotics Corporation increase decrease in operating lease liability for fiscal 2023 was $4.99M, a 1425.69% increase from fiscal 2022.
- PROCEPT BioRobotics Corporation increase decrease in operating lease liability for fiscal 2022 was $327.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-02 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $2.60M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $2.60M 10-Q · filed 2025-11-05 | $2.60M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.60M 10-Q · filed 2025-08-07 | $2.60M derived: sum of 3 quarters · filed 2026-02-26 | $2.60M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $2.60M 10-Q · filed 2025-05-02 | $2.60M derived: sum of 2 quarters · filed 2026-02-26 | $2.60M derived: sum of 3 quarters · filed 2026-02-26 | $4.37M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $1.77M derived: sum of 3 quarters · filed 2026-02-26 | $4.99M 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | $1.77M derived: sum of 2 quarters · filed 2024-10-28 | $4.99M 10-Q · filed 2024-10-28 | $5.32M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $4.99M 10-Q · filed 2024-08-02 | $5.32M derived: sum of 3 quarters · filed 2025-02-27 | $5.32M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $3.22M 10-Q · filed 2024-05-02 | $3.54M derived: sum of 2 quarters · filed 2025-02-27 | $3.54M derived: sum of 3 quarters · filed 2025-02-27 | $3.54M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $327.00K derived: sum of 2 quarters · filed 2025-02-27 | $327.00K derived: sum of 3 quarters · filed 2025-02-27 | $327.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $0.00 derived: sum of 2 quarters · filed 2023-11-02 | $0.00 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $0.00 10-Q · filed 2023-07-28 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |